Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. A recent review article published in the Journal of Clinical Investigation summarized the adverse effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual incretin receptor agonists such as tirzepatide. Of … Read more
When her doctor died suddenly in August, Tammy MacDonald found herself among the roughly 17% of adults in America without a primary care physician. MacDonald wanted to find a new doctor right away. She needed refills for her blood pressure medications and wanted to book a follow-up appointment after a breast cancer scare. She called … Read more
Hair lossnausea, etc. … The weight loss injection is seen as a beacon of hope for… The post Weight Loss Injections: Risks & Counterfeits – Gütersloh Doctor Warns appeared first on Archynetys. Source link
A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without causing nausea. The discovery, made at the University of Gothenburg, could pave the way for better drugs to treat obesity. Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown … Read more
As ketogenic diets grow in popularity, a new review sheds light on the short-term side effects of keto-induction and offers science-backed solutions to help manage the dreaded “keto flu.” Symptoms during initiation of a ketogenic diet: a scoping review of occurrence rates, mechanisms and relief strategies. Image Credit: eldar nurkovic / Shutterstock In a recent study published … Read more
Archyde Beyond teh Divide: Rethinking Functional Dyspepsia and Gastroparesis in 2025 Table of Contents 1. Beyond teh Divide: Rethinking Functional Dyspepsia and Gastroparesis in 2025 2. The Blurring Lines of Gut Disorders 3. Symptom Overlap: Where Does One Disorder End and Another Begin? 4. Unraveling the Underlying Mechanisms 5. The Gut Microbiome: A Key Player? … Read more
Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can’t produce enough insulin. During DKA the body starts breaking down fat, causing a buildup of acids in the bloodstream. The symptoms often include thirst, weakness, nausea and confusion. Concerningly, this condition accounts for more than 500,000 hospital days per year, … Read more
Functional dyspepsia (FD) and gastroparesis (GP) are gastrointestinal disorders often managed as separate conditions. FD is classified as a disorder of gut-brain interaction (DGBI), characterized by symptoms such as early satiety, postprandial fullness, and epigastric pain without structural abnormalities. In contrast, GP is a neuromuscular disorder diagnosed based on delayed gastric emptying (GE), typically presenting … Read more
We know now that glucagon-like peptide 1 (GLP-1) drugs for obesity bring with them a whole host of other potential benefits, as well as a handful of side effects. But new research has brought a sharper focus on both the pros and the cons of these medications, and with that comes new challenges and opportunities … Read more